Header Logo

Connection

Michael Wenger to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Michael Wenger has written about Antibodies, Monoclonal, Humanized.
Michael Wenger
Connection Strength
0.104
Antibodies, Monoclonal, Humanized
  1. Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions. N Engl J Med. 2014 Mar 20; 370(12):1101-10.
    View in: PubMed
    Score: 0.104
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.